Tower Research Capital LLC (TRC) - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$111,540
-70.5%
2,704
-60.0%
0.00%
-76.9%
Q2 2023$377,590
+100056.5%
6,762
+0.1%
0.01%
+8.3%
Q1 2023$377
+255.7%
6,758
+132.9%
0.01%
+200.0%
Q4 2022$106
-100.0%
2,902
-85.0%
0.00%
-55.6%
Q3 2022$551,000
-30.1%
19,347
+11.2%
0.01%
-50.0%
Q2 2022$788,000
+35.2%
17,398
+127.2%
0.02%
+200.0%
Q1 2022$583,000
-3.2%
7,657
+89.7%
0.01%
-40.0%
Q4 2021$602,000
+58.4%
4,037
+54.4%
0.01%0.0%
Q3 2021$380,000
-86.4%
2,615
-81.7%
0.01%
-86.3%
Q2 2021$2,795,000
-1.8%
14,273
-9.2%
0.07%
+52.1%
Q1 2021$2,846,000
+466.9%
15,725
+343.5%
0.05%
+220.0%
Q4 2020$502,000
+1631.0%
3,546
+1408.9%
0.02%
Q3 2020$29,000
-63.3%
235
-73.4%
0.00%
-100.0%
Q2 2020$79,000
-80.3%
883
-83.2%
0.00%
-90.9%
Q4 2019$401,000
+60.4%
5,263
+6.3%
0.03%
+94.1%
Q3 2019$250,0004,9520.02%
Other shareholders
10X GENOMICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 750,000$111,720,00099.68%
Foresite Capital Management II, LLC 1,753,528$261,206,00099.34%
Venrock Management VI, LLC 962,309$143,346,00096.17%
12 West Capital Management LP 2,004,000$298,516,00013.24%
FINANCIAL CONSULATE, INC 154,942$23,080,0008.00%
Meritech Capital Associates V L.L.C. 1,610,824$239,948,0007.68%
Andar Capital Management HK Ltd 55,000$8,193,0007.52%
JS Capital Management LLC 540,589$80,526,0003.66%
HARVARD MANAGEMENT CO INC 186,143$27,728,0002.60%
Connective Portfolio Management, LLC 7,000$1,056,0001.86%
View complete list of 10X GENOMICS INC shareholders